Management of HIV/HCV Coinfection in 2014: Cure for All?
Jürgen Rockstroh, MD, PhD
Senior Physician, Department of Internal Medicine
University Hospital of Bonn, Germany
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2014. All rights reserved.
Jürgen Rockstroh is Professor of Medicine and Head of the HIV Outpatient Clinic at the University of Bonn in Germany. In addition to his clinical practice, Dr Rockstroh is involved in HIV research on: antiretroviral therapy, including new drug classes; the course of HIV disease in hemophiliacs; and HIV and hepatitis co-infection. He was the Chairman of the German Clinical AIDS Working Group (KAAD) from 1998 to 2007, was elected as the president of the German AIDS Society from 2007 to 2011, and, since 2009, he is also a member of the executive committee of the European AIDS Clinical Society (EACS). He chaired the organizing committee for the First and Second International Workshops on HIV and Hepatitis Co-Infection in 2004 and 2005 in Amsterdam, and was on the international organizing committee for the First European Consensus Conference on the Treatment of Chronic Hepatitis B and C in HIV Co-Infected Patients in 2005. He currently chairs the hepatitis research activities in the European AIDS Treatment Network (NEAT) and EuroSIDA.
At the completion of this educational session, learners will:
- Be familiar with the current treatment algorithms for HCV therapy in HIV coinfection.
- Be able to identify suitable candidates for treatment of HCV with underlying HIV coinfection.
- Know current DAA based treatment approaches for HCV with HIV coinfection.
- Be aware of prediction factors for HCV treatment response as well as presentation of adverse event management.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.
